Sale!

GGCX Gene Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “GGCX Gene Pseudoxanthoma Elasticum-Like Disorder with Multiple Coagulation Factor Deficiency Genetic Test” is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the GGCX gene. This gene is crucial for the activation of certain proteins involved in blood coagulation and the health of connective tissues. Mutations in the GGCX gene can lead to a rare condition that exhibits characteristics similar to pseudoxanthoma elasticum, including abnormal mineralization of elastic fibers in tissues and a deficiency in multiple blood coagulation factors, leading to increased bleeding risk.

The test, which costs 4400 AED, involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any genetic abnormalities in the GGCX gene that may indicate the presence of this disorder. This genetic test is critical for early diagnosis and management of the condition, allowing for appropriate treatment plans to be devised to manage symptoms and prevent complications associated with coagulation deficiencies and connective tissue disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test

The GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test is a genetic test that analyzes the GGCX gene for mutations associated with a condition called pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency. This rare genetic disorder affects the connective tissues in various parts of the body, including the skin, eyes, and blood vessels. It is characterized by the progressive calcification and fragmentation of elastic fibers, leading to the development of yellowish bumps on the skin, vision problems, and cardiovascular complications.

The GGCX gene is responsible for encoding the gamma-glutamyl carboxylase enzyme, which plays a crucial role in the activation of certain coagulation factors and proteins involved in the formation of blood clots. Mutations in the GGCX gene can impair the function of the gamma-glutamyl carboxylase enzyme, leading to a deficiency in the activation of coagulation factors. This can result in a bleeding disorder, characterized by prolonged bleeding and easy bruising.

The GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test utilizes NGS (Next-Generation Sequencing) technology, which allows for the simultaneous analysis of multiple genes, including the GGCX gene, in a single test. This technology enables the detection of various types of genetic mutations, such as point mutations, insertions, deletions, and rearrangements, providing a comprehensive analysis of the GGCX gene.

The cost of the GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test is AED 4400.0. The test can be performed on blood or extracted DNA, or by using one drop of blood on an FTA card. The report delivery time is approximately 3 to 4 weeks.

To undergo the GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test, a patient should provide their clinical history and may need to participate in a genetic counseling session to draw a pedigree chart of family members affected by the condition. The test is conducted by a hematologist in the Genetics department.

The results of the GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test can help confirm a diagnosis of pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency and guide appropriate management and treatment options. It can also provide valuable information for genetic counseling and family planning.

Test Name GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency NGS Genetic DNA Test gene GGCX
Test Details

GGCX Gene Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency NGS Genetic Test is a genetic test that analyzes the GGCX gene for mutations associated with a condition called pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency.

Pseudoxanthoma elasticum-like disorder is a rare genetic disorder that affects the connective tissues in various parts of the body, including the skin, eyes, and blood vessels. It is characterized by the progressive calcification and fragmentation of elastic fibers, leading to the development of yellowish bumps on the skin, vision problems, and cardiovascular complications.

This genetic test specifically looks for mutations in the GGCX gene, which is responsible for encoding the gamma-glutamyl carboxylase enzyme. This enzyme plays a crucial role in the activation of certain coagulation factors and proteins involved in the formation of blood clots.

Mutations in the GGCX gene can impair the function of the gamma-glutamyl carboxylase enzyme, leading to a deficiency in the activation of coagulation factors. This can result in a bleeding disorder, characterized by prolonged bleeding and easy bruising.

The NGS (Next-Generation Sequencing) technology used in this genetic test allows for the simultaneous analysis of multiple genes, including the GGCX gene, in a single test. It enables the detection of various types of genetic mutations, such as point mutations, insertions, deletions, and rearrangements, providing a comprehensive analysis of the GGCX gene.

The results of this genetic test can help in confirming a diagnosis of pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency and guide appropriate management and treatment options. It can also provide information for genetic counseling and family planning.